Back to Home

Pharmacy & Drug Policy

Expert articles and analysis related to pharmacy & drug policy.

198 articlesLast 30 Days

AI Summary — Last 30 Days

Over the past 30 days, CMS has finalized the Contract Year 2027 Medicare Advantage and Part D rule, codifying significant redesigns to Part D benefit structures and updating risk adjustment methodology to differentiate payments between MA-PDs and stand-alone PDPs—directly impacting plan revenue streams and risk strategies for value-based care organizations (CY 2027 MA/Part D Rule: Key Implications, [2027

Related Articles

100ALN

Under the Magnifying Glass: A Wave of Drug Price Transparency

ajmc.comApr 1, 2026
100ALN

Public Opinion on Prescription Drugs and Their Prices

This chart collection draws on recent KFF poll findings to provide an in-depth look at the public's attitudes toward prescription drugs and their prices. Results include the U.S. public’s experiences ...

kff.orgMar 31, 2026
100ALN

Bipartisan bill would cap insulin at $35 per month

Bipartisan bill would cap insulin at $35 per month  Becker's Hospital Review

beckershospitalreview.comMar 26, 2026
100ALN

Understanding The Explanations For The 2027 Medicare Drug Price Negotiation Cycle

Understanding The Explanations For The 2027 Medicare Drug Price Negotiation Cycle  Health Affairs

healthaffairs.orgMar 26, 2026
100ALN

IRA Drug Provisions Linked to Significant Drop in Medicare Medication Nonadherence

ajmc.comMar 25, 2026
100ALN

CVS reaches insulin pricing settlement with FTC

CVS reaches insulin pricing settlement with FTC  Health Leaders Media

healthleadersmedia.comMar 25, 2026
100ALN

CVS Caremark, FTC reach settlement in insulin pricing case

CVS Caremark, FTC reach settlement in insulin pricing case  Fierce Healthcare

fiercehealthcare.comMar 24, 2026
100ALN

STAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access

The FTC said the settlement will save Americans up to $7 billion in out-of-pocket costs over 10 years.

statnews.comMar 24, 2026
90ALN

STAT+: Trump administration prepares 100% tariffs on some imported drugs

The White House is readying a 100% tax on some imported medicines, a draft order shows.

statnews.comApr 2, 2026
90ALN

What has been the main impact of MFN?

It is not bringing down US prices, but delaying launches in Europe. Reuters reports: Drug launches in EU markets fell by some 35% in the 10 months since Trump’s executive order, compared with the prev...

healthcare-economist.comApr 1, 2026